[ad_1] Merck & Co.’s $10.8 billion acquisition of Prometheus Biosciences Inc., which it announced Sunday,…
PFE
-
-
STOCK MARKET
How a nasal vaccine could reduce the risk of COVID infections — and new variants
by userby user[ad_1] For many, one of the defining moments of the COVID-19 pandemic was when they…
-
STOCK MARKET
Pfizer’s $43 billion bid for Seagen aims to broaden company’s cancer portfolio
by userby user[ad_1] Pfizer’s PFE, +1.50% proposed acquisition of Seagen SGEN, +15.29%, which develops cancer treatments, for…
-
STOCK MARKET
Pfizer eyes takeover of biotech Seagen, at value of more than $30 billion
by userby user[ad_1] Pfizer Inc. PFE, -1.30% is in talks to acquire biotech Seagen Inc. SGEN, -0.51%, according to people…
-
STOCK MARKET
‘Ukraine is open for business’: Western companies urged to be part of Ukrainian recovery
by userby user[ad_1] A year to the day since Russia launched its devastating invasion of Ukraine, western…
-
STOCK MARKET
After IPO, Bausch + Lomb turns to an industry favorite to run the company
by userby user[ad_1] Bausch + Lomb Corp.’s decision to bring back Brent Saunders as CEO hints at…
-
STOCK MARKET
Pfizer’s COVID revenues have dropped off along with attention to the pandemic
by userby user[ad_1] Pfizer PFE, +0.10% put out its yearly sales guidance for Comirnaty, the COVID-19 vaccine…
-
STOCK MARKET
Biden to end U.S. COVID emergencies on May 11, but more than 500 people are still dying every day
by userby user[ad_1] President Joe Biden will end the twin national emergencies for addressing COVID-19 on May…
-
[ad_1] Pfizer’s PFE, -0.92% early-stage pipeline, though promising, is still too premature to make up…
-
STOCK MARKET
WHO calls on China to release more information on its COVID case surge to learn more about which variants are circulating
by userby user[ad_1] The World Health Organization has called on China to release more information about its…